Regenicin, Inc. reported earnings results for the full year ended September 30, 2022. For the full year, the company reported net loss was USD 0.639262 million compared to USD 0.670602 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 15.35K | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- RGIN Stock
- News Regenicin, Inc.
- Regenicin, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022